Document Detail

Duration of action and hemodynamic properties of mivacurium chloride in dogs anesthetized with halothane.
MedLine Citation:
PMID:  10490069     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To describe onset and duration of neuromuscular blockade induced by mivacurium chloride and its associated hemodynamic effects at 3 dosages in healthy dogs. ANIMALS: 7 Labrador Retrievers. PROCEDURE: Anesthesia was induced with thiopental and maintained with halothane in oxygen, and dogs were mechanically ventilated to end-tidal P(CO)2 between 35 and 40 mm Hg. Core temperature, end-tidal P(CO)2, and halothane concentration were kept constant throughout the experiment. Neuromuscular function was assessed by evaluation of the train-of-four response to a supramaximal electrical stimulus of 2 Hz applied to the ulnar nerve every 10 seconds. Blood for determination of plasma cholinesterase activity was obtained prior to administration of mivacurium, a bolus of which was administered IV, using a randomized Latin-square design for dosages of 0.01, 0.02, and 0.05 mg/kg of body weight. RESULTS: All dogs had typical plasma cholinesterase activity. After administration of mivacurium, differences were not evident between groups in heart rate, systolic, mean, or diastolic blood pressure, change at any time in heart rate, systolic, mean, or diastolic blood pressure, or pH. Interval from onset to 100% neuromuscular blockade was 3.92+/-1.70, 2.42+/-0.53, and 1.63+/-0.25 minutes at dosages of 0.01, 0.02, and 0.05 mg/kg, respectively. Duration of measurable neuromuscular blockade was 33.72+/-12.73, 65.38+/-12.82, and 151.0+/-38.50 minutes, respectively. Time of onset and duration of effect differed significantly among dosages. CONCLUSIONS AND CLINICAL RELEVANCE: Mivacurium provides good hemodynamic stability at the dosages tested. In dogs, this drug has a rapid onset and long duration of effect.
L J Smith; P F Moon; V M Lukasik; H N Erb
Related Documents :
17315439 - Anesthetic management of an orangutan (pongo abelii/pygmaeus) undergoing laparoscopic t...
3826859 - Anesthetic interaction in cardiovascular research models: effects of xylazine and pento...
17040309 - Anesthesia management with short acting agents for bilateral pheochromocytoma removal i...
24002229 - Microseismic monitoring of co2 injection at the penn west enhanced oil recovery pilot p...
7014099 - Phenytoin for brain resuscitation after cardiac arrest: an uncontrolled clinical trial.
12059889 - Electrophysiologic cardiac effects of the new local anesthetic iqb-9302 and of bupivaca...
1724539 - Implication of the central nervous system in the systemic and regional hemodynamics of ...
22526259 - Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: sys...
2668819 - A new method for sonographic urethrocystography and simultaneous pressure-flow measurem...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of veterinary research     Volume:  60     ISSN:  0002-9645     ISO Abbreviation:  Am. J. Vet. Res.     Publication Date:  1999 Sep 
Date Detail:
Created Date:  1999-11-01     Completed Date:  1999-11-01     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0375011     Medline TA:  Am J Vet Res     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1047-50     Citation Subset:  IM    
Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anesthesia / veterinary
Body Temperature
Cholinesterases / blood
Dogs / physiology*
Electric Stimulation
Electroencephalography / veterinary
Halothane / therapeutic use
Hemodynamics / drug effects*,  physiology
Injections, Intravenous / veterinary
Isoquinolines / pharmacology*
Neuromuscular Nondepolarizing Agents / pharmacology*
Random Allocation
Ulnar Nerve / drug effects*
Reg. No./Substance:
0/Isoquinolines; 0/Neuromuscular Nondepolarizing Agents; 106791-40-6/mivacurium; 151-67-7/Halothane; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A polymerase chain reaction screening strategy for the promoter of the canine dystrophin gene.
Next Document:  Pharmacokinetic variables of mivacurium chloride after intravenous administration in dogs.